UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Artificial riboswitches for gene expression and replication control of DNA and RNA viruses

Proceedings of the National Academy of Sciences - PNAS, 2014-02, Vol.111 (5), p.1674-1674

2014

Volltextzugriff (PDF)

Moving oncolytic viruses into the clinic: clinical-grade production, purification, and characterization of diverse oncolytic viruses

Molecular therapy. Methods & clinical development, 2016-01, Vol.3 (C), p.16018-16018, Article 16018

2016

Volltextzugriff (PDF)

MicroRNA-sensitive oncolytic measles virus for chemovirotherapy of pancreatic cancer

Molecular therapy. Oncolytics, 2021-06, Vol.21, p.340-355

2021

Volltextzugriff (PDF)

Enhanced Control of Oncolytic Measles Virus Using MicroRNA Target Sites

Molecular therapy. Oncolytics, 2018-06, Vol.9, p.30-40

2018

Volltextzugriff (PDF)

Attenuated and protease-profile modified sendai virus vectors as a new tool for virotherapy of solid tumors

PloS one, 2014-03, Vol.9 (3), p.e90508-e90508

2014

Volltextzugriff (PDF)

De Novo Synthesis of N and P Proteins as a Key Step in Sendai Virus Gene Expression

Journal of Virology, 2007-12, Vol.81 (24), p.13835-13844

2007

Volltextzugriff (PDF)

CTLA-4 and PD-L1 Checkpoint Blockade Enhances Oncolytic Measles Virus Therapy

Molecular therapy, 2014-11, Vol.22 (11), p.1949-1959

2014

Volltextzugriff (PDF)

A Chimeric Respiratory Syncytial Virus Fusion Protein Functionally Replaces the F and HN Glycoproteins in Recombinant Sendai Virus

Journal of Virology, 2005-08, Vol.79 (16), p.10467-10477

2005

Volltextzugriff (PDF)

Enhanced killing of therapy‐induced senescent tumor cells by oncolytic measles vaccine viruses

International journal of cancer, 2014-01, Vol.134 (1), p.235-243

2014

Volltextzugriff (PDF)

Granulocyte-macrophage colony-stimulating factor-armed oncolytic measles virus is an effective therapeutic cancer vaccine

Human gene therapy, 2013-07, Vol.24 (7), p.644-654

2013

Volltextzugriff (PDF)

MicroRNA-sensitive Oncolytic Measles Viruses for Cancer-specific Vector Tropism

Molecular therapy, 2011-06, Vol.19 (6), p.1097-1106

2011

Volltextzugriff (PDF)

A novel armed oncolytic measles vaccine virus for the treatment of cholangiocarcinoma

Human gene therapy, 2013-05, Vol.24 (5), p.554-564

2013

Volltextzugriff (PDF)

Sequencing of serially passaged measles virus affirms its genomic stability and reveals a nonrandom distribution of consensus mutations

Journal of general virology, 2020-04, Vol.101 (4), p.399-409

2020

Volltextzugriff (PDF)

Severe Impairment of Dendritic Cell Allostimulatory Activity by Sendai Virus Vectors Is Overcome by Matrix Protein Gene Deletion

Journal of Immunology, 2005-10, Vol.175 (8), p.4971-4980

2005

Volltextzugriff (PDF)

A Tupaia paramyxovirus vector system for targeting and transgene expression

Journal of general virology, 2017-09, Vol.98 (9), p.2248-2257

2017

Volltextzugriff (PDF)

Negative-Strand RNA Viral Vectors: Intravenous Application of Sendai Virus Vectors for the Systemic Delivery of Therapeutic Genes

Molecular therapy, 2003-02, Vol.7 (2), p.210-217

2003

Volltextzugriff (PDF)

Chemovirotherapy of Malignant Melanoma with a Targeted and Armed Oncolytic Measles Virus

Journal of investigative dermatology, 2013-04, Vol.133 (4), p.1034-1042

2013

Volltextzugriff (PDF)

626. Improving MicroRNA-Target-Site-Based Vector Control

Molecular therapy, 2015-05, Vol.23, p.S248-S249

2015

Volltextzugriff (PDF)

Evaluation of a novel immunogenic vaccine platform based on a genome replication-deficient Sendai vector

Vaccine, 2013-08, Vol.31 (37), p.3888-3893

2013

Volltextzugriff (PDF)

Recombinant Sendai virus induces T cell immunity against respiratory syncytial virus that is protective in the absence of antibodies

Cellular immunology, 2007-06, Vol.247 (2), p.85-94

2007

Volltextzugriff (PDF)

Attenuated and Protease-Profile Modified Sendai Virus Vectors as a New Tool for Virotherapy of Solid Tumors: e90508

PloS one, 2014-03, Vol.9 (3)

2014

Volltextzugriff (PDF)

477. Replication Deficiency: The Safety Record of a New Sendai Virus Vector Generation

Molecular therapy, 2006-05, Vol.13 (S1), p.S185-S185

2006

Volltextzugriff (PDF)

Sendai virus trailer RNA simultaneously blocks two apoptosis-inducing mechanisms in a cell type-dependent manner

Journal of general virology, 2005-08, Vol.86 (8), p.2305-2314

2005

Volltextzugriff (PDF)

Evaluation of nucleocapsid and phosphoprotein p functionality as critical factors during the early phase of paramyxoviral infection

The open virology journal, 2012, Vol.6 (1), p.73-81

2012

Volltextzugriff (PDF)

840. Recombinant Sendai Virus Vectors with Matrix Protein Gene Deletion Restore Dendritic Cell Allostimulatory Activity

Molecular therapy, 2005-05, Vol.11 (S1), p.S326-S326

2005

Volltextzugriff (PDF)

1 – 25 von 33

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(32)
Mit Volltextzugriff
(31)

Publikationsform

Artikel
(32)
Buchkapitel
(1)

Sprache

Englisch
(33)

Erscheinungsjahr

n.n

Thema

Science & Technology
(24)
Life Sciences & Biomedicine
(22)
Animals
(16)
Humans
(12)
Sendai Virus
(11)
Sendai Virus - Genetics
(11)
Viruses
(10)
Biotechnology & Applied Microbiology
(9)
Genomes
(9)
Medicine, Research & Experimental
(9)
Mice
(9)
Research & Experimental Medicine
(9)
Virology
(9)
Cercopithecus Aethiops
(8)
Proteins
(8)
Vero Cells
(8)
Biological And Medical Sciences
(7)
Gene Expression
(7)
Measles Virus
(7)
Gene Therapy
(6)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Artificial riboswitches for gene expression and replication control of DNA and RNA viruses

Moving oncolytic viruses into the clinic: clinical-grade production, purification, and characterization of diverse oncolytic viruses

MicroRNA-sensitive oncolytic measles virus for chemovirotherapy of pancreatic cancer

Enhanced Control of Oncolytic Measles Virus Using MicroRNA Target Sites

Attenuated and protease-profile modified sendai virus vectors as a new tool for virotherapy of solid tumors

De Novo Synthesis of N and P Proteins as a Key Step in Sendai Virus Gene Expression

CTLA-4 and PD-L1 Checkpoint Blockade Enhances Oncolytic Measles Virus Therapy

A Chimeric Respiratory Syncytial Virus Fusion Protein Functionally Replaces the F and HN Glycoproteins in Recombinant Sendai Virus

Enhanced killing of therapy‐induced senescent tumor cells by oncolytic measles vaccine viruses

Granulocyte-macrophage colony-stimulating factor-armed oncolytic measles virus is an effective therapeutic cancer vaccine

MicroRNA-sensitive Oncolytic Measles Viruses for Cancer-specific Vector Tropism

A novel armed oncolytic measles vaccine virus for the treatment of cholangiocarcinoma

Sequencing of serially passaged measles virus affirms its genomic stability and reveals a nonrandom distribution of consensus mutations

Severe Impairment of Dendritic Cell Allostimulatory Activity by Sendai Virus Vectors Is Overcome by Matrix Protein Gene Deletion

A Tupaia paramyxovirus vector system for targeting and transgene expression

Negative-Strand RNA Viral Vectors: Intravenous Application of Sendai Virus Vectors for the Systemic Delivery of Therapeutic Genes

Chemovirotherapy of Malignant Melanoma with a Targeted and Armed Oncolytic Measles Virus

626. Improving MicroRNA-Target-Site-Based Vector Control

Evaluation of a novel immunogenic vaccine platform based on a genome replication-deficient Sendai vector

Recombinant Sendai virus induces T cell immunity against respiratory syncytial virus that is protective in the absence of antibodies

Attenuated and Protease-Profile Modified Sendai Virus Vectors as a New Tool for Virotherapy of Solid Tumors: e90508

477. Replication Deficiency: The Safety Record of a New Sendai Virus Vector Generation

Sendai virus trailer RNA simultaneously blocks two apoptosis-inducing mechanisms in a cell type-dependent manner

Evaluation of nucleocapsid and phosphoprotein p functionality as critical factors during the early phase of paramyxoviral infection

840. Recombinant Sendai Virus Vectors with Matrix Protein Gene Deletion Restore Dendritic Cell Allostimulatory Activity

Suchergebnisse filtern